Carolyn Tang

2021

In 2021, Carolyn Tang earned a total compensation of $2.9M as General Counsel at Arcus Biosciences, a 30% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$200,000
Option Awards$1,852,686
Salary$400,000
Stock Awards$460,521
Other$3,200
Total$2,916,407

Tang received $1.9M in option awards, accounting for 64% of the total pay in 2021.

Tang also received $200K in non-equity incentive plan, $400K in salary, $460.5K in stock awards and $3.2K in other compensation.

Rankings

In 2021, Carolyn Tang's compensation ranked 4,535th out of 12,415 executives tracked by ExecPay. In other words, Tang earned more than 63.5% of executives.

ClassificationRankingPercentile
All
4,535
out of 12,415
64th
Division
Manufacturing
1,876
out of 5,505
66th
Major group
Chemicals And Allied Products
781
out of 2,375
67th
Industry group
Drugs
695
out of 2,096
67th
Industry
Pharmaceutical Preparations
496
out of 1,546
68th

Pay ratio

Carolyn Tang's Pay$2,916,407
Median Employee's Pay$296,616
Pay Ratio

10

to 1

In 2021, the annual total compensation of Carolyn Tang was $2,916,407.

The annual total compensation of the median employee at Arcus Biosciences was $296,616.

The ratio of Carolyn Tang's pay to the pay of median employee was therefore 10 to one.

Source: SEC filing on April 20, 2022.

Tang's colleagues

We found five more compensation records of executives who worked with Carolyn Tang at Arcus Biosciences in 2021.

2021

Jennifer Jarrett

Arcus Biosciences

Chief Operating Officer

2021

Terry Rosen

Arcus Biosciences

Chief Executive Officer

2021

Juan Jaen

Arcus Biosciences

President and Director

2021

William Grossman

Arcus Biosciences

Chief Medical Officer

2021

Robert Goeltz

Arcus Biosciences

Chief Financial Officer

News

In-depth

You may also like